|
|
|
Crestor - Class Action Information
|
Crestor labeling includes warnings about the potential for muscle and kidney problems, but warning labels may not be
adequate enough and may be insufficient if your physician lacks knowledge about the dangers crestor poses. These dangers
can lead side effects that cause someone to file a Crestor lawsuit.
Crestor became the sixth cholesterol lowering statin drug on the U.S. market when it was approved by the Food and
Drug Administration on August 13, 2003. The other members of the statin family are atorvastatin (brand-name Lipitor),
fluvastatin (Lescol), lovastatin (Mevacor), pravastatin (Pravachol), and simvastatin (Zocor). The statin cerivastatin
(Baycol), was removed from the market.
Since Crestor was approved sixteen patients in the United States that took Crestor developed health problems.
A press release from Dr. Sidney Wolfe, Health Research Director of Public Citizen states, "Crestor is already showing signs
that it is too dangerous for people to take, and it is only a matter of time, after 'enough' people have been injured or
killed, that Crestor will have to be pulled from the market." Dr. Wolfe went on to say, "The FDA should never have approved
Crestor in the face of such serious and potentially lethal adverse effects. The only way the agency can show it has concern
for patient safety, and not industry wishes, is to pull Crestor from the market immediately."
Return to Main
|
|
